Microvascular and macrovascular complications in children and adolescents

Kim C Donaghuea,b, R Paul Wadwac, Linda A Dimegliod, Tien Y Wonge, Francesco Chiarellif, M Loredana Marcovecchiof, Mona Salemg, Jamal Razah, Paul L Hofmani and Maria E Craiga,b,j aInstitute of Endocrinology and Diabetes, The Children’s Hospital at Westmead, Sydney, Australia; bDiscipline of Paediatrics and Child Health, University of Sydney, Sydney, Australia; cBarbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Denver, CO, USA; dPediatric Endocrinology and Diabetology, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, USA; eSingapore National Eye Centre, Singapore Eye Research Institute, Singapore, Singapore; fDepartment of Paediatrics, University of Chieti, Chieti, Italy; gDepartment of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt; hNational Institute of Child Health, Karachi, Pakistan; iLiggins Institute, University of Auckland, Auckland, New Zealand and jSchool of Women’s and Children’s Health, University of New South Wales, Sydney, Australia

[1]  Tien Yin Wong,et al.  Kidney and eye diseases: common risk factors, etiological mechanisms, and pathways. , 2014, Kidney international.

[2]  L. E. Lovblom,et al.  Does the Prevailing Hypothesis That Small-Fiber Dysfunction Precedes Large-Fiber Dysfunction Apply to Type 1 Diabetic Patients? , 2014, Diabetes Care.

[3]  M. Craig,et al.  Puberty as an accelerator for diabetes complications , 2014, Pediatric diabetes.

[4]  F. Kardelen,et al.  Investigation of endothelial dysfunction and arterial stiffness in children with type 1 diabetes mellitus and the association with diastolic dysfunction , 2014, Diabetes & vascular disease research.

[5]  F. Wolf Standards of Medical Care in Diabetes—2014 , 2013, Diabetes Care.

[6]  Jasmin Divers,et al.  Peripheral Neuropathy in Adolescents and Young Adults With Type 1 and Type 2 Diabetes From the SEARCH for Diabetes in Youth Follow-up Cohort , 2013, Diabetes Care.

[7]  Wei-Chih Liao,et al.  Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis , 2013, BMJ.

[8]  E. Wiltshire,et al.  Folate fortification and supplementation do not provide vascular health benefits in type 1 diabetes. , 2013, The Journal of pediatrics.

[9]  M. Craig,et al.  Autonomic neuropathy in young people with type 1 diabetes: a systematic review , 2013, Pediatric diabetes.

[10]  A. Sjølie,et al.  Is Smoking a Risk Factor for Proliferative Diabetic Retinopathy in Type 1 Diabetes? , 2013, Ophthalmologica.

[11]  B. Klein,et al.  Assessing Progress in Retinopathy Outcomes in Type 1 Diabetes , 2013, Diabetes Care.

[12]  R. Beck,et al.  Most Youth With Type 1 Diabetes in the T1D Exchange Clinic Registry Do Not Meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes Clinical Guidelines , 2013, Diabetes Care.

[13]  J. Craig,et al.  Antihypertensive agents for preventing diabetic kidney disease. , 2012, The Cochrane database of systematic reviews.

[14]  J. Baldi,et al.  Diastolic Function Is Reduced in Adolescents With Type 1 Diabetes in Response to Exercise , 2012, Diabetes Care.

[15]  G. Simonetti,et al.  Pregnancy Outcome Following Exposure to Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Antagonists: A Systematic Review , 2012, Hypertension.

[16]  P. Baghurst,et al.  Hypoglycemia, but not glucose variability, relates to vascular function in children with type 1 diabetes. , 2012, Diabetes technology & therapeutics.

[17]  Hong Huang,et al.  Hyperglycemia Increases Muscle Blood Flow and Alters Endothelial Function in Adolescents with Type 1 Diabetes , 2012, Experimental diabetes research.

[18]  B. Klein,et al.  Global Prevalence and Major Risk Factors of Diabetic Retinopathy , 2012, Diabetes Care.

[19]  M. Craig,et al.  Microvascular complications assessment in adolescents with 2‐ to 5‐yr duration of type 1 diabetes from 1990 to 2006 , 2011, Pediatric diabetes.

[20]  M. Rewers,et al.  Obesity and coronary artery calcium in diabetes: the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study. , 2011, Diabetes technology & therapeutics.

[21]  R. Hoffmann,et al.  Impaired Endothelial Function in Preadolescent Children With Type 1 Diabetes , 2011, Diabetes Care.

[22]  Rayaz A. Malik,et al.  Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments , 2010, Diabetes Care.

[23]  R. G. Miller,et al.  In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study , 2010, Diabetologia.

[24]  J. Baldi,et al.  Effect of reduced total blood volume on left ventricular volumes and kinetics in type 2 diabetes , 2010, Acta physiologica.

[25]  S. Daniels,et al.  Prevalence of increased arterial stiffness in children with type 1 diabetes mellitus differs by measurement site and sex: the SEARCH for Diabetes in Youth Study. , 2010, The Journal of pediatrics.

[26]  C. Forsblom,et al.  Age at Onset and the Risk of Proliferative Retinopathy in Type 1 Diabetes , 2010, Diabetes Care.

[27]  Neil H. White,et al.  Effect of Prior Intensive Therapy in Type 1 Diabetes on 10-Year Progression of Retinopathy in the DCCT/EDIC: Comparison of Adults and Adolescents , 2010, Diabetes.

[28]  J. Couper,et al.  Aortic intima media thickness is an early marker of atherosclerosis in children with type 1 diabetes mellitus. , 2010, The Journal of pediatrics.

[29]  R. Klein,et al.  Rates of Progression in Diabetic Retinopathy During Different Time Periods , 2009, Diabetes Care.

[30]  H. Tildesley,et al.  Apolipoprotein B levels in adults with type 1 diabetes not receiving lipid-lowering therapy. , 2009, Clinical biochemistry.

[31]  B. Groves,et al.  Cardiac dysfunction during exercise in uncomplicated type 2 diabetes. , 2009, Medicine and science in sports and exercise.

[32]  Merlin C. Thomas,et al.  The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes , 2009, Diabetes.

[33]  R. Danielsen,et al.  Factors contributing to left ventricular diastolic dysfunction in long-term type I diabetic subjects. , 2009, Acta medica Scandinavica.

[34]  K. Borch-Johnsen,et al.  Cardiovascular risk factors in type I (insulin-dependent) diabetic patients with and without proteinuria. , 2009, Acta medica Scandinavica.

[35]  J. Todd,et al.  Ambulatory blood pressure measurements are related to albumin excretion and are predictive for risk of microalbuminuria in young people with type 1 diabetes , 2009, Diabetologia.

[36]  R. Wadwa,et al.  Lipid and Lipoprotein Profiles in Youth With and Without Type 1 Diabetes , 2008, Diabetes Care.

[37]  S. Twigg,et al.  Timing Is Everything: Age of Onset Influences Long-Term Retinopathy Risk in Type 2 Diabetes, Independent of Traditional Risk Factors , 2008, Diabetes Care.

[38]  M. Craig,et al.  Role of blood pressure in development of early retinopathy in adolescents with type 1 diabetes: prospective cohort study , 2008, BMJ : British Medical Journal.

[39]  J. Baldi,et al.  Impaired stroke volume and aerobic capacity in female adolescents with type 1 and type 2 diabetes mellitus , 2008, Diabetologia.

[40]  D. Dunger,et al.  Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study , 2008, BMJ : British Medical Journal.

[41]  N. Øverby,et al.  High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study , 2008, Diabetologia.

[42]  R Peto,et al.  Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. , 2008, Lancet.

[43]  D. Maahs,et al.  Higher Prevalence of Elevated Albumin Excretion in Youth With Type 2 Than Type 1 Diabetes , 2007, Diabetes Care.

[44]  T. Jones,et al.  Diabetes care, glycemic control, and complications in children with type 1 diabetes from Asia and the Western Pacific Region. , 2007, Journal of diabetes and its complications.

[45]  T. Wong,et al.  Management of diabetic retinopathy: a systematic review. , 2007, JAMA.

[46]  G. Remuzzi,et al.  Kidney failure stabilizes after a two-decade increase: impact on global (renal and cardiovascular) health. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[47]  J. Craig,et al.  Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. , 2006, The Cochrane database of systematic reviews.

[48]  F. Fazio,et al.  Persistent Renal Hypertrophy and Faster Decline of Glomerular Filtration Rate Precede the Development of Microalbuminuria in Type 1 Diabetes , 2006, Diabetes.

[49]  E. Wiltshire,et al.  Folate and Vitamin B6 Rapidly Normalize Endothelial Dysfunction In Children With Type 1 Diabetes Mellitus , 2006, Pediatrics.

[50]  N. Clark,et al.  Standards of Medical Care in Diabetes: Response to Power , 2006 .

[51]  B. Zinman,et al.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.

[52]  D. Maahs,et al.  Total cholesterol and high-density lipoprotein levels in pediatric subjects with type 1 diabetes mellitus. , 2005, The Journal of pediatrics.

[53]  D. Dunger,et al.  The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study. , 2005, Kidney international.

[54]  S. Dib,et al.  Aerobic exercise capacity in normal adolescents and those with type 1 diabetes mellitus , 2005, Pediatric diabetes.

[55]  H. Parving,et al.  Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study. , 2005, Kidney international.

[56]  M. Craig,et al.  Discordant trends in microvascular complications in adolescents with type 1 diabetes from 1990 to 2002. , 2005, Diabetes care.

[57]  P. Rossing The changing epidemiology of diabetic microangiopathy in type 1 diabetes , 2005, Diabetologia.

[58]  P. Crock,et al.  Prevalence of diabetes complications 6 years after diagnosis in an incident cohort of childhood diabetes , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[59]  J. Hokanson,et al.  Awareness and treatment of dyslipidemia in young adults with type 1 diabetes. , 2005, Diabetes care.

[60]  M. Craig,et al.  The case for biennial retinopathy screening in children and adolescents. , 2005, Diabetes care.

[61]  Richard Platt,et al.  Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. , 2004, JAMA.

[62]  J. Craig,et al.  Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review , 2004, BMJ : British Medical Journal.

[63]  B. Rosner,et al.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents , 2004 .

[64]  Thomas H Marwick,et al.  Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. , 2004, Endocrine reviews.

[65]  Isabel Rey Madeira,et al.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. , 2004, Pediatrics.

[66]  H. Büller,et al.  Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study , 2004, JAMA.

[67]  J. Ellis,et al.  Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease , 2004, British Journal of Ophthalmology.

[68]  D. Lackland,et al.  Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. , 2004, Investigative ophthalmology & visual science.

[69]  S. Shahinfar,et al.  A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension. , 2003, American journal of hypertension.

[70]  P. Scanlon,et al.  Comparison of two reference standards in validating two field mydriatic digital photography as a method of screening for diabetic retinopathy , 2003, The British journal of ophthalmology.

[71]  D. Lackland,et al.  Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy. , 2003, Kidney international.

[72]  J. Olson,et al.  A comparative evaluation of digital imaging, retinal photography and optometrist examination in screening for diabetic retinopathy , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[73]  Sarah Parish,et al.  MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial , 2003, The Lancet.

[74]  Andrzej S Krolewski,et al.  Regression of microalbuminuria in type 1 diabetes. , 2003, The New England journal of medicine.

[75]  A. J. Swerdlow,et al.  Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes , 2003, Diabetologia.

[76]  Braxton D Mitchell,et al.  The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. , 2003, Diabetes care.

[77]  M. Craig,et al.  Do all prepubertal years of diabetes duration contribute equally to diabetes complications? , 2003, Diabetes care.

[78]  D. Lackland,et al.  Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia. , 2003, Diabetes care.

[79]  M. Mercuri,et al.  Efficacy and Safety of Statin Therapy in Children With Familial Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled Trial With Simvastatin , 2002, Circulation.

[80]  J. Redón,et al.  Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. , 2002, The New England journal of medicine.

[81]  Leiv Sandvik,et al.  Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control. , 2002, Diabetes.

[82]  M. Blumenkranz,et al.  The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. , 2002, American journal of ophthalmology.

[83]  S. Shahinfar,et al.  A Double‐Blind, Placebo‐Controlled, Dose‐Response Study of the Effectiveness and Safety of Enalapril for Children with Hypertension , 2002, Journal of clinical pharmacology.

[84]  H. Parving,et al.  Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. , 2002, Diabetes care.

[85]  M. Taskinen,et al.  Family histories of Type II diabetes and hypertension predict intima–media thickness in patients with Type I diabetes , 2002, Diabetologia.

[86]  H. Dorchy,et al.  Risk factors of developing proliferative retinopathy in type 1 diabetic patients : role of BMI. , 2002, Diabetes care.

[87]  J. Fuller,et al.  Factors associated with plasma lipids and lipoproteins in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[88]  S. Twyman,et al.  Longitudinal study of urinary albumin excretion in young diabetic patients–‐Wessex Diabetic Nephropathy Project , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[89]  N. Chaturvedi Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data. , 2001, Annals of internal medicine.

[90]  Diabetes Control Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. , 2000, Diabetes care.

[91]  C. Fortin,et al.  Impact of left ventricular diastolic dysfunction on maximal treadmill performance in normotensive subjects with well-controlled type 2 diabetes mellitus. , 2000, The American journal of cardiology.

[92]  G. Watts,et al.  Endothelial dysfunction in Type 2 diabetic subjects with and without microalbuminuria. , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[93]  D. Dunger,et al.  Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group. , 1999, Diabetes care.

[94]  J M Sparrow,et al.  The national diabetic retinopathy laser treatment audit III. Clinical outcomes , 1999, Eye.

[95]  P. Hopkins,et al.  Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. , 1999, JAMA.

[96]  T. Elhadd,et al.  Elevated Plasma Vascular Endothelial Cell Growth Factor and Thrombomodulin in Juvenile Diabetic Patients , 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[97]  S. Greene,et al.  Influence of puberty on endothelial dysfunction and oxidative stress in young patients with type 1 diabetes. , 1998, Diabetes care.

[98]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[99]  T. Jones,et al.  Progression of borderline increases in albuminuria in adolescents with insulin‐dependent diabetes mellitus , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[100]  F. Ferris Early photocoagulation in patients with either type I or type II diabetes. , 1997, Transactions of the American Ophthalmological Society.

[101]  T. Danne,et al.  Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. , 1997, The Journal of pediatrics.

[102]  M. Muggeo,et al.  Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. , 1996, Diabetes care.

[103]  M. Muggeo,et al.  Cardiovascular Disease and Its Risk Factors in IDDM in Europe , 1996, Diabetes Care.

[104]  S. Rudberg,et al.  Determinants of Progression of Microalbuminuria in Adolescents With IDDM , 1996, Diabetes Care.

[105]  H. Parving,et al.  Prevention of diabetic renal disease with special reference to microalbuminuria , 1995, The Lancet.

[106]  A. Donker,et al.  Endothelial Dysfunction Precedes Development of Microalbuminuria in IDDM , 1995, Diabetes.

[107]  N. Sharpe,et al.  Comparison of echocardiographic variables between type I diabetics and normal controls. , 1995, The American journal of cardiology.

[108]  J. Couper,et al.  Relationship of Smoking and Albuminuria in Children with Insulin‐dependent Diabetes , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[109]  Diabetes Control Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. , 1994, The Journal of pediatrics.

[110]  D. Rogers,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus , 1994 .

[111]  J Ludvigsson,et al.  Declining incidence of nephropathy in insulin-dependent diabetes mellitus. , 1994, The New England journal of medicine.

[112]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[113]  R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[114]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[115]  R. Hamman,et al.  Smokers with IDDM Experience Excess Morbidity: The Colorado IDDM Registry , 1992, Diabetes Care.

[116]  H. Parving Impact of Blood Pressure and Antihypertensive Treatment on Incipient and Overt Nephropathy, Retinopathy, and Endothelial Permeability in Diabetes Mellitus , 1991, Diabetes Care.

[117]  E. Seaquist,et al.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. , 1989, The New England journal of medicine.

[118]  P. Andersen,et al.  The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus , 1985, Diabetologia.

[119]  C. Mogensen,et al.  Predicting diabetic nephropathy in insulin-dependent patients. , 1984, The New England journal of medicine.

[120]  K. Johansen,et al.  Incipient nephropathy in Type 1 (insulin-dependent) diabetes , 1984, Diabetologia.

[121]  D. DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. , 1984, Archives of ophthalmology.

[122]  H. Keen,et al.  MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS , 1982, The Lancet.

[123]  M. Abbal,et al.  FACTOR-VIII COMPLEX AND ENDOTHELIAL DAMAGE , 1975, The Lancet.

[124]  S. Twigg,et al.  Long-Term Complications and Mortality in Young-Onset Diabetes Type 2 diabetes is more hazardous and lethal than type 1 diabetes , 2013 .

[125]  Jennifer W Talton,et al.  Reduced Heart Rate Variability Among YouthWith Type 1 Diabetes The SEARCH CVD study , 2012 .

[126]  D. Theriaque,et al.  Pediatric Atorvastatin in Diabetes Trial (PADIT): A Pilot Study to Determine the Effect of Atorvastatin on Arterial Stiffness and Endothelial Function in Children with Type 1 Diabetes Mellitus , 2009, Journal of pediatric endocrinology & metabolism : JPEM.

[127]  M. Craig,et al.  The Case for Biennial Retinopathy Screening in Children and Adolescents: Response to Stefánsson , 2006 .

[128]  D. Power Standards of medical care in diabetes. , 2006, Diabetes care.

[129]  D. Raev Left ventricular function and specific diabetic complications in other target organs in young insulin-dependent diabetics: An echocardiographic study , 2005, Heart and Vessels.

[130]  L. V. Van Gaal,et al.  Impact of overweight on chronic microvascular complications in type 1 diabetic patients. , 2005, Diabetes care.

[131]  S. Daniels,et al.  Clinical and research aspects of ambulatory blood pressure monitoring in children. , 2004, The Journal of pediatrics.

[132]  S. Hori Guidelines for the Management of Diabetic Retinopathy for the Internist , 2002 .

[133]  P A Cleary,et al.  Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). , 2001, The Journal of pediatrics.

[134]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[135]  Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. , 1998, Archives of ophthalmology.

[136]  O. Jolobe Angiotensin-converting enzyme inhibitors. , 1995, British journal of hospital medicine.

[137]  A. Kriska,et al.  Insulin-dependent diabetes mellitus, physical activity, and death. , 1993, American journal of epidemiology.

[138]  J. Wetzels,et al.  The changing natural history of nephropathy in type I diabetes. , 1986, The American journal of medicine.

[139]  Curtis L. Meinert,et al.  Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. , 1978, Ophthalmology.